Clinicopathologic characteristics and outcomes to immune checkpoint inhibitor therapy in patients with HER2-altered metastatic non-small cell lung cancer

被引：0
|
作者：
Makarem, M. [1 ]
Ricciuti, B. [1 ]
Alessi, J. V. [1 ]
Pecci, F. [1 ]
Di Federico, A. [1 ]
Gandhi, M. [1 ]
Janne, P. A. [1 ]
Awad, M. M. [1 ]
Rotow, J. K. [1 ]
机构：
[1] Lowe Ctr Thorac Oncol, Dana Farber Canc Inst, Boston, MA USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.980
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2198P
引用
收藏
页码：S1136 / S1136
页数：1
相关论文
共 50 条
  • [21] Early discontinuation of immune checkpoint inhibitor therapy prior to disease progression in patients with metastatic non-small cell lung cancer: a survival analysis
    McKinley, Blake J.
    Pai, Tanmayi S.
    Wolf, Emily B.
    Li, Shenduo
    Correia, Guilherme Sacchi de Camargo
    Zhao, Yujie
    Manochakian, Rami
    Lou, Yanyan
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [22] Retreatment with nivolumab and ipilimumab with or without chemotherapy in patients with metastatic non-small cell lung cancer after progression on immune checkpoint inhibitor therapy
    Mederos, Nuria
    Bouchaab, Hasna
    Veillard, Jennifer
    Tu Nguyen-Ngoc
    Doumenc, Thibault
    Michielin, Olivier
    Pradervand, Sylvain
    Wicky, Alexandre M.
    Cuendet, Michel
    Peters, Solange
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [23] Mining metastatic lymph nodes for response to immune checkpoint therapy in non-small cell lung cancer
    Donders, E.
    ANNALS OF ONCOLOGY, 2024, 35 : S271 - S271
  • [24] Characteristics, incidence, and risk factors of immune checkpoint inhibitor related pneumonitis in patients with non-small cell lung cancer
    Cho, Jun Yeun
    Kim, Junghoon
    Lee, Jong Seok
    Kim, Yu Jung
    Kim, Se Hyun
    Lee, Yeon Joo
    Cho, Young-Jae
    Yoon, Ho Il
    Lee, Jae Ho
    Lee, Choon-Taek
    Park, Jong Sun
    LUNG CANCER, 2018, 125 : 150 - 156
  • [25] Radiation Therapy and Checkpoint Inhibitors in Older Patients with Metastatic Non-Small Cell Lung Cancer
    Li, Y. R.
    Tran, Q. L.
    Golden, E. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S225 - S226
  • [26] Increased Hepatotoxicity Associated with Sequential Immune Checkpoint Inhibitor and Crizotinib Therapy in Patients with Non-Small Cell Lung Cancer
    Lin, Jessica J.
    Chin, Emily
    Yeap, Beow Y.
    Ferris, Lorin A.
    Kamesan, Vashine
    Lennes, Inga T.
    Sequist, Lecia V.
    Heist, Rebecca S.
    Mino-Kenudson, Mari
    Gainor, Justin F.
    Shaw, Alice T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (01) : 135 - 140
  • [27] Association of Opioid Use with Survival in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitor Therapy
    Mock, J.
    Wynter, E.
    Young, P.
    Sytov, A.
    Elghawy, O.
    Gentzler, R.
    Novicoff, W.
    Martin, L.
    Hall, R.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S20 - S21
  • [28] Real-world characteristics and outcomes of patients with advanced non-small cell lung cancer (aNSCLC) receiving immune checkpoint inhibitor.
    Khozin, Sean
    Zhi, Jizu
    Jun, Monika
    Chen, Li
    Rubinstein, Wendy S.
    Walker, Mark S.
    Komatsoulis, George Anthony
    Roberts, Jeremy
    Fukushima, Ryan
    Lau, Denise
    Hyde, Brigham
    Stepanski, Edward
    Miller, Robert S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [29] Genomic and immune characteristics of HER2-mutated non-small-cell lung cancer and response to immune checkpoint inhibitor-based therapy
    Tu, Hai-Yan
    Yin, Kai
    Zhao, Xiaotian
    Ke, E-E
    Wu, Si-Pei
    Li, Yang-Si
    Zheng, Mei-Mei
    Liu, Si-Yang Maggie
    Xu, Chong-Rui
    Sun, Yue-Li
    Lin, Jia-Xin
    Bai, Xiao-Yan
    Zhang, Yi-Chen
    Zhou, Qing
    Yang, Jin-Ji
    Zhong, Wen-Zhao
    Wang, Bing-Chao
    Zhang, Xu-Chao
    Zhu, Dongqin
    Yang, Lingling
    Ou, Qiuxiang
    Wu, Yi-Long
    MOLECULAR ONCOLOGY, 2023, 17 (08) : 1581 - 1594
  • [30] Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer
    Takeuchi, Eiji
    Kondo, Kensuke
    Okano, Yoshio
    Kunishige, Michihiro
    Kondo, Yoshihiro
    Kadota, Naoki
    Machida, Hisanori
    Hatakeyama, Nobuo
    Naruse, Keishi
    Ogino, Hirokazu
    Nokihara, Hiroshi
    Shinohara, Tsutomu
    Nishioka, Yasuhiko
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3139 - 3147
12345